Analytical Services CDMOs

NextPharma

Finland

NextPharma is a European pharmaceutical CDMO headquartered in Finland with 10 manufacturing sites across Europe. The company provides pharmaceutical development, clinical trial supply, commercial manufacturing, packaging, and analytical services across a wide range of dosage forms including solids, semi-solids, liquids, softgel capsules, ophthalmics, modified release products, and specialist areas such as hormones, cephalosporins, penicillins, and narcotics.

NGL Fine Chem Limited

India

NGL Fine-Chem Limited is an Indian pharmaceutical company incorporated in 1981, manufacturing APIs and intermediates for both veterinary (animal health) and human health applications. The company operates manufacturing plants around Mumbai with capabilities for custom synthesis and contract manufacturing, serving global pharmaceutical companies with a focus on product quality, reliability, and cost effectiveness.

Nifty Labs Pvt. Ltd.

India

Nifty Labs Pvt. Ltd. is an Indian API and advanced intermediate manufacturer based in Hyderabad, established in 2005. The company operates USFDA, EU GMP, KFDA, and PMDA-approved manufacturing facilities. Through its wholly-owned subsidiary Nifty Pharma, it also manufactures semi-finished dosage forms (pellets with various release profiles). The facility has four production blocks with process equipment handling 0.1L to 7kL batch sizes.

Nippon Shokubai Co., Ltd. (Health & Medical Business)

Japan

Nippon Shokubai's Health & Medical Business division operates as a CDMO specializing in oligonucleotide and peptide API manufacturing. The company has two oligonucleotide synthesis/purification lines and one peptide line, making it one of Japan's largest manufacturers in this sector. A tenfold GMP capacity expansion (several kg/batch) is planned for 2027 to meet growing global demand for nucleic acid drug APIs.

NJ Bio, Inc.

India

NJ Bio, Inc. is a premier CRO/CDMO specializing in antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates, and related bioconjugation chemistry. The company provides integrated chemistry services from discovery through GMP manufacturing, including custom synthesis of payloads, linkers, drug-linkers, and bioconjugation. NJ Bio has facilities in Princeton, New Jersey with specialized laboratories for high-potency API handling.

Nortec Química S.A.

Brazil

Nortec Quimica is the largest Active Pharmaceutical Ingredient (API) manufacturer in Latin America, operating since 1985 in Duque de Caxias, Brazil. The company produces over 50 APIs, with strong expertise in local anesthetics (lidocaine, bupivacaine, prilocaine, articaine, mepivacaine), as well as escetamine and olanzapine. Nortec offers a complete CDMO platform from R&D through commercial-scale API production.

Northway Biotech

Lithuania

Northway Biotech is a global end-to-end biologics CDMO specializing in protein-based biologics and gene therapies. The company operates state-of-the-art facilities in Vilnius, Lithuania (EU) and Waltham, Massachusetts (US), with 20+ years of technical expertise. Northway offers cell line development, process development, analytical development, and cGMP manufacturing of drug substances and drug products using both mammalian cell culture and microbial fermentation technologies.

NorthX Biologics

Sweden

NorthX Biologics is a Swedish CDMO specializing in advanced biologics and ATMPs (Advanced Therapy Medicinal Products). The company offers end-to-end services from process development to GMP manufacturing for recombinant proteins, viral vectors, plasmid DNA, cell therapy, extracellular vesicles, and mRNA. Recognized by the Swedish Government as an international competence center and innovation hub in 2021, NorthX has 30+ years of GMP manufacturing experience.

Numaferm GmbH

Germany

Numaferm GmbH is a German biotech company specializing in the biochemical production of peptides and proteins using its proprietary Numaswitch and Numatech expression platforms. The company offers contract development and manufacturing services from discovery through commercial/GMP supply, partnering with established CMOs for large-scale production. Numaferm has completed over 200 successful peptide projects and is ISO 9001:2015 certified.

OBiO Tech (OBiO Technology)

China

OBiO Technology (Shanghai) Corp., Ltd (688238.SH) is a China-based biotechnology company and CRO/CDMO group focusing on cell and gene therapy. The company provides end-to-end offerings including process development, analytical method development, IND-enabling CMC, and clinical and commercial contract manufacturing of viral vectors, oncolytic viruses, and cell therapy products. OBiO operates a 10,000-square-meter GMP campus (Intelli-M PINE Site) with 29 GMP production lines.

Ofichem Group

Netherlands

Ofichem Group is a family-owned European CDMO and pharmaceutical supplier founded in 1975, headquartered in Ter Apel, Netherlands. The company provides end-to-end services from drug substance (API) development through finished drug product manufacturing, including sourcing and distribution. Ofichem has recently expanded through acquisitions of Meribel Pharma Solutions' Uppsala site (early-phase development, ADCs, oligonucleotides, PROTACs) and Avivia (formulation development).

O.F.I. Officina Farmaceutica Italiana

Italy

O.F.I. Officina Farmaceutica Italiana is an Italian contract development and manufacturing company established in 1946, specializing in food supplements, medical devices, and dermo-cosmetic products. The company provides full-service contract manufacturing from idea generation to production, with capabilities in tablets, capsules, creams, gels, probiotics, and sterile processes. OFI holds ISO certifications including ISO 13485 (medical devices) and is FDA approved and Halal certified.

OmniaBio Inc

Canada

OmniaBio Inc is Canada's largest cell and gene therapy CDMO, established by CCRM in 2022. The company provides end-to-end contract development and manufacturing services for autologous and allogeneic cell therapies, lentiviral vectors, and immunotherapies. Its Hamilton, Ontario facility integrates AI, automation, and robotics to enhance manufacturing efficiency and reduce costs.

OneSource Specialty Pharma Limited

India

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) is India's first specialty pharma pure-play CDMO, offering multimodal end-to-end capabilities across drug-device combinations, complex sterile injectables, biologics, and soft gelatin capsules. The company operates five state-of-the-art facilities in Bengaluru with 35 approved ANDAs and 19 commercialized drug products in the US market.

Opocrin SpA

Italy

Opocrin SpA is an Italian pharmaceutical company with nearly 60 years of experience, recognized as a global leader in the research, production, and commercialization of active pharmaceutical ingredients and complex molecules, with a specialization in heparins and their derivatives. The company also produces glycosaminoglycans, iron complexes, and pulmonary surfactants.

Orchev Pharma Pvt Ltd

India

Orchev Pharma Pvt. Ltd., established in 1989 in Gujarat, India, is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates specializing in Ranitidine HCl, Famotidine, Telmisartan, and Levetiracetam. The facility is US-FDA, EU-GMP (AEMPS), WHO-GMP, KFDA, and COFEPRIS certified. USFDA inspection in 2018 was cleared with zero 483 observations.

Oxford Biomedica (OXB)

United Kingdom

Oxford Biomedica (OXB) is a global, quality- and innovation-led CDMO specializing in viral vector development and manufacturing for cell and gene therapy. With 25+ years of experience, OXB is the first and currently only FDA-approved CDMO for commercial production of lentiviral vectors for CAR-T therapy. The company operates GMP suites across three countries with extensive end-to-end capabilities in lentivirus, AAV, and adenovirus vectors.

Pagari PharmaTech, INC.

India

Pagari PharmaTech, INC. is a U.S.-based CDMO offering concept-to-commercialization services including Research and Development, Analytical Services, Technology Transfer, and Manufacturing Services for Solid and Liquid Oral Dosage Forms as well as OTC and Prescription (Rx) Drug Products. The company adheres to FDA, EMA, and ICH guidelines with support for IND, NDA, ANDA, and 505(b)(2) submissions. Small company (2-10 employees per LinkedIn), based in India with U.S. manufacturing services.

PharmaBlock Group

China

PharmaBlock Group is the parent entity of PharmaBlock (Stock code: 300725.SZSE), a leading CRDMO with 2,300 employees and 700+ global partners across 7 sites. The group provides building blocks, chemistry research, drug substance CDMO, and drug product CDMO services. It holds an EcoVadis Silver Medal for sustainability. Note: this is the same company as PharmaBlock (duplicate entry).

Pharmicell Chemical

South Korea

Pharmicell Co., Ltd. is a South Korean biopharmaceutical company operating both chemical (API) and biologics (stem cell therapy) divisions, with CDMO services. The Chemical Business Unit in Ulsan (Onsan) manufactures oligonucleosides, pharmaceutical PEGs, and industrial advanced materials. The Bio division developed the world's first approved stem cell therapy (Hearticellgram AMI for cardiac repair) and provides CDMO services for advanced cell therapies with GMP facilities including Grade B/C clean rooms, virus testing labs, and microorganism testing labs. The company holds ISO 9001, ISO 14001 certifications and reported record revenue of 114 billion KRW in 2025. Pharmicell is expanding CDMO operations for regenerative medicine with capability to handle 7 cell types.

Phyton Biotech

Canada

Phyton Biotech is the world's largest provider of Plant Cell Fermentation (PCF) technology, producing paclitaxel and docetaxel (key oncology APIs). Offers comprehensive contract product/process development and commercial manufacturing services for high-value active ingredients from fermentation. Operates GMP commercial manufacturing facilities in Germany and Canada, both US FDA and Health Canada approved. Recently received Controlled Substances Dealers License from Health Canada.

piCHEM (The Peptide Company)

Austria

piCHEM is a privately owned Austrian company with over three decades of experience in the manufacturing of synthetic peptides and peptide-related molecules. Provides full GMP service for peptides used as active pharmaceutical ingredients (APIs), including process scale-up, process validation, analytical services, stability studies, and regulatory support. Also manufactures peptide precursors for radiopharmaceuticals/nuclear medicine. Offers aseptic fill & finish services in-house or through qualified partners. EU-GMP/cGMP certified, FDA registered for API manufacture.

PLD Pharma Services

United States

PLD Pharma Services (formerly Avema Pharma Solutions) is the CDMO division of PL Developments, providing development, manufacturing, and packaging for liquid and solid dose delivery systems based on small molecule APIs. Over three decades of expertise spanning OTC, Rx, diagnostics, and dietary supplements. Offers formulation development, method development & validation, regulatory expertise, and packaging. Recently expanded into pharmaceutical-grade gummy manufacturing in Copaigue, NY.

PolyPeptide Group

Switzerland

PolyPeptide Group AG (SIX: PPGN) is a specialized global CDMO and market leader in peptide-based active pharmaceutical ingredient manufacturing. Supports pharmaceutical and biotech companies from pre-clinical through commercial scale. Operates six production sites worldwide with over 70 years of experience and 1,000+ GMP peptides manufactured. Strong exposure to GLP-1 therapies for metabolic diseases (diabetes, obesity). Currently expanding with a EUR 100M investment to double solid-phase peptide synthesis capacity at Malmo, Sweden. Also expanding in Belgium and Ambernath, India. Recently added oligonucleotide capabilities. Publicly traded on SIX Swiss Exchange.

Procos S.p.A.

Italy

Procos S.p.A. is an Italian CDMO established in 1945, now a wholly owned subsidiary of Japanese company CBC Co. Ltd Group, specializing in the development, scale-up, and production of Active Pharmaceutical Ingredients (APIs), high potency APIs (HPAPIs), and advanced intermediates. The company operates a 155,000 sq meter cGMP multipurpose manufacturing site in Cameri, Italy, with production capacity exceeding 350 metric tons. The facility has been successfully audited by AIFA, FDA, and PMDA.

ProteoGenix SAS

France

ProteoGenix SAS is a French antibody production company founded in 2003, providing integrated solutions for custom antibody development, recombinant protein expression, and bioproduction services. The company offers therapeutic antibody discovery, humanization using proprietary AI, ADC development, bispecific antibody development, CAR-T platforms, and custom cell line development across 6 manufacturing sites. ProteoGenix serves the therapeutics, diagnostics, research, and animal health markets.

Protheragen-ING

China

Protheragen-ING is a China-based comprehensive integrated service provider specializing in drug development and biotechnology solutions. The company offers both small molecule and large molecule (antibody, ADC, protein therapy) development and manufacturing services, with an extensive pipeline of available drug development projects spanning antibody therapies, oncolytic virotherapy, cell therapy (CAR-T), and small molecules. Protheragen is FDA-registered for API manufacture and operates project incubation and equity investment services for drug candidates.

Purisys

United States

Purisys is a US-based CDMO specializing in custom Active Pharmaceutical Ingredients (APIs) and chemical synthesis projects, with over 40 years of commercial pharmaceutical production experience. The company is a global leader in pharmaceutical-grade cannabinoids and psychedelic compounds, with DEA-secure manufacturing capabilities. Purisys also offers reference standard synthesis and qualification with over 300 commercial standards. The company was recently acquired by Siegfried alongside Noramco.

Quality Chemical Laboratories (QCL)

United States

Quality Chemical Laboratories (QCL) is a US-based CDMO located in Wilmington, North Carolina, specializing in comprehensive analytical testing, formulation development, and GMP clinical manufacturing. The company offers API synthesis, method development, taste masking, enteric coating, tablet film coating, and controlled/immediate release formulation development. QCL is FDA-registered for analysis, API manufacture, drug product manufacturing, and packaging.

Quotient Sciences

United Kingdom

Quotient Sciences is a UK-headquartered pharmaceutical CRDMO (contract research, development, and manufacturing organization) specializing in small molecule and synthetic peptide drug product development and manufacturing. They offer integrated formulation development, clinical manufacturing, and commercial production, with their proprietary Translational Pharmaceutics approach integrating clinical activities with real-time cGMP manufacturing. They have facilities in the US and UK, with capabilities including HPAPI manufacturing, sterile fill/finish, and oral solid dose.

QuVA Pharma

United States

QuVA Pharma is a US-based FDA-registered 503B outsourcing facility specializing in sterile compounding of ready-to-administer injectable medicines for hospitals. They serve over 3,000 US hospitals and operate multiple manufacturing and forward distribution centers. They also offer AI-powered analytics (Quva BrightStream) for health-system pharmacy data insights. Notable regulatory history includes multiple OAI inspections and Class I/II recalls.

Raritan Pharmaceuticals, Inc.

United States

Raritan Pharmaceuticals is a US-based contract manufacturer specializing in OTC pharmaceuticals, consumer products, and high-end cosmetics. They develop, manufacture, and market generic OTC medicines and niche OTC brands. Their expertise includes chewable tablets, fast-dissolving tablets, powders, capsules, specialty liquids, gels, ointments, creams, and film-delivery systems. They operate from East Brunswick, NJ with FDA-registered manufacturing facilities. Notable regulatory history includes multiple recalls (15 Class II) and OAI inspection.

RD‑Biotech

France

RD-Biotech is a French biotechnology CRO/CDMO founded in 2002, offering custom solutions in molecular biology, immunology, and cellular engineering for R&D, preclinical, and clinical programs. They specialize in plasmid DNA production (including GMP grade), monoclonal antibodies, recombinant antibodies, recombinant proteins, and cell culture/banking. They have a strategic partnership with ABL for cell and gene therapy GMP manufacturing.

Recipharm AB

Sweden

Rechon Life Science AB is a subsidiary/entity within the Recipharm group, the global CDMO headquartered in Stockholm, Sweden. This entry represents the same Recipharm organization (same website: recipharm.com) with its extensive global manufacturing footprint of 15+ FDA-registered FEI numbers and 52 FDA inspections. The Perplexity research confirms Recipharm's specialization in oral solid dose, inhalation, sterile manufacturing, and HPAPI capabilities. Rechon may represent a specific Recipharm site or legacy entity. Duplicate of Recipharm AB entry -- capabilities are identical.

ReiThera Srl

Italy

ReiThera is an Italian CDMO dedicated to process development and GMP manufacturing of viral vectors for genetic vaccines and advanced therapy medicinal products (ATMPs). They have extensive expertise in developing scalable processes for Adeno-Associated Vectors (AAV), Lentivirus, Adenoviral vectors (AdV), Modified Vaccinia Ankara, and Herpes Simplex Vectors. Their state-of-the-art facility in Rome features stirred-tank bioreactors at 50L, 200L, 1000L, and 2000L scales, fixed-bed bioreactors, a filling suite, and quality control laboratories. They also develop their own vaccine candidates (e.g., GRAd-COV2).

REMEDICA LTD

Cyprus

REMEDICA is a Cyprus-based pharmaceutical manufacturer that has been operating for over four decades, distributing products in more than 160 countries. They manufacture generics across multiple therapeutic areas and dosage forms (solid oral dose, liquids, semi-solids, sterile injectables) and offer contract manufacturing (CMO/CDMO) services. They have long-standing relationships with NGOs (UNICEF, WHO, UNRWA). They focus on B2B partnerships, own-brand commercialization (Cyprus, Eastern EU, Asia, Middle East, Africa, LATAM), and NGO supply.

Renejix Pharma Solutions

United States

Renejix Pharma Solutions (operating as HyCON Labs) is a US-based CDMO specializing in small molecule oral dosage form development and multi-modality manufacturing. The company offers end-to-end services from preformulation through commercial manufacturing, with 14+ technologies, 300+ pieces of equipment, 350+ employees, and 2+ facilities. They serve as a single-partner CDMO across all development stages.

Rezon Bio

Poland

Rezon Bio is a European biologics CDMO headquartered in Poland, specializing in mammalian drug substance development and GMP manufacturing. The company operates two FDA-approved facilities with mirrored capabilities, employs approximately 1,300 people (10% PhDs), and has 16 years of biologics development experience. Rezon Bio offers end-to-end services from cell line development through commercial manufacturing with 2,000L bioreactors.

RiboPro B.V.

Netherlands

RiboPro B.V. is a Netherlands-based mRNA CDMO providing GMP-grade mRNA manufacturing, LNP (lipid nanoparticle) formulation services, and contract research. The company has over a decade of mRNA-specific experience and offers proprietary technologies including RiboStealth sequence optimization and RiboFlux GMP manufacturing platform. RiboPro serves customers ranging from early discovery through commercial production of mRNA therapeutics and vaccines.

R L Fine Chem Pvt Ltd

India

R L Fine Chem Pvt Ltd (RLFC) is an Indian API manufacturer established in 1984, pioneering the development and production of psychotropic and CNS substances in India. The company exports APIs to over 80 countries across the globe, with a leadership position in multiple therapeutic areas including anti-depressants, anti-psychotics, anxiolytics, anti-convulsants, anti-histamines, anti-malarials, and hypnotics. RLFC operates multiple GMP manufacturing plants with DSIR-approved R&D.

Roslin Cell Therapies Ltd

United Kingdom

Roslin Cell Therapies Ltd (trading as RoslinCT) is a leading global CDMO focused exclusively on advanced cell therapies. Originally spun out from the Roslin Institute in Edinburgh, Scotland, the company merged with Lykan Bioscience in 2022 and received significant investment from GHO Capital. RoslinCT provides contract development and GMP manufacturing services for cell therapy products, operating facilities in Edinburgh, UK and Hopkinton, MA, USA.

Sanzyme Biologics Pvt Ltd

India

Sanzyme Biologics is one of India's leading probiotic manufacturers with over five decades of fermentation expertise, originally established by Daiichi Sankyo, Japan. The company operates two manufacturing facilities in Hyderabad with combined fermentation capacity exceeding 350,000L, providing contract manufacturing services for probiotic strains, enzymes, and metabolites for pharmaceutical, food, and supplement applications.

Saurav Chemicals Ltd

India

Saurav Chemicals Ltd (SCL Lifesciences) is an Indian manufacturer of Active Pharmaceutical Ingredients and advanced intermediates, with over three decades of experience serving regulated markets in Europe, the USA, and Japan. The company is the largest supplier of cephalosporin and penem intermediates and also provides CDMO services, custom synthesis, and mRNA vaccine ingredients.

Scientific Protein Laboratories (SPL)

United States

Scientific Protein Laboratories (SPL) is a CDMO specializing in cGMP biopharmaceutical manufacturing of APIs from biological sources, with over 30 years of experience. Core products include heparin derivatives (Heparin Sodium USP) and pancreatic enzymes (Pancreatin USP, Pancrelipase USP). The company also provides custom development services including fermentation, natural product extractions, and recovery/purification of therapeutic proteins from preclinical through commercial scale.

Scinai Immunotherapeutics

Israel

Scinai Immunotherapeutics is a NASDAQ-listed biopharmaceutical company that provides boutique biologics CDMO services through its Scinai Bioservices business unit, alongside its own I&I therapeutics pipeline. The CDMO offers end-to-end drug development and manufacturing from molecule selection through Phase 3 manufacturing, with over 20 years of experience in recombinant protein development. Scinai acquired a manufacturing site in Yavne, Israel from Recipharm and established a US subsidiary (Scinai Bioservices Inc.).

SCN BestCo

United States

SCN BestCo is a contract manufacturer of innovative pharmaceutical dosage forms for OTC drugs, vitamins, and dietary supplements. It specializes in gummy, soft chew, coated chew, and lozenge dosage forms and operates as a contract manufacturer of consumer healthcare products since 1976.

Scorpius BioManufacturing

United States

Scorpius BioManufacturing is a US-based biologics CDMO focused on mammalian, microbial, and cell therapy manufacturing. The company provides cGMP manufacturing, bioanalytical, and process development services from its San Antonio, Texas facility. Note: Tivic Health acquired manufacturing assets from Scorpius, and the company has undergone corporate restructuring under Scorpius Holdings / NightHawk Biosciences.

SCTbio

Czechia

SCTbio is a Czech CDMO specializing in cell and gene therapy (ATMP) manufacturing, spun out from SOTIO. The company provides cGMP production of cell-based therapies and retroviral/lentiviral vectors from its 2,000 sqm facility in Prague, Czech Republic. SCTbio has specialized expertise in dendritic cell therapeutics, CAR-T, and viral vector production, supported by a global network of 150 apheresis collection centers.